Governing the AI–biotech convergence
The convergence of artificial intelligence with biotechnology accelerates innovation but also introduces significant ethical and security risks. These require adaptive, flexible governance strategies that ensure that breakthroughs can be managed responsibly while mitigating potential risks.
Authors
- Benjamin D. Trump (ORCID: https://orcid.org/0000-0002-4097-733X)
- Tatyana Novossiolova (ORCID: https://orcid.org/0000-0002-1097-7259)
- Christopher L. Cummings (ORCID: https://orcid.org/0000-0002-3840-556X)
- Christian Haggenmiller
- Travis B. Tubbs (ORCID: https://orcid.org/0000-0001-5887-1085)
- Stephanie Galaitsi (ORCID: https://orcid.org/0000-0002-2318-491X)
- Ruth Mampuys (ORCID: https://orcid.org/0000-0002-6090-4015)
- Gerald L. Epstein (ORCID: https://orcid.org/0000-0001-7286-034X)
- Hannah Herzig
- Beth Ellinport
- Markus Schmidt
- Igor Linkov
- James H Lambert
- Elizaveta Pinigina
- Thomas Janisko
- Cindy S Groff-Vindman
- Alexander Titus
Institutions
- United States Army Corps of Engineers (US)
- RAND Corporation (US)
- Center for the Study of Democracy (BG)
- Directorate-General for Health and Food Safety (BE)
- United States Army (US)
- Biofaction (Austria) (AT)
- Westbrook University (US)
- Design Intelligence (United States) (US)
- Hamburg Institut (Germany) (DE)
- United States Air Force Academy (US)
- University of Virginia (US)
- Analysis Group (United States) (US)
- U.S. Army Engineer Research and Development Center (US)
- Scientific Council for Government Policy (NL)
Publication Details
- Journal
- EMBO Reports
- Published
- 2026-01-03
- DOI
- https://doi.org/10.1038/s44319-025-00628-w
- Primary Topic
- Law, AI, and Intellectual Property
- Type
- article
- Field-Weighted Citation Impact
- 0.00